CLINICAL_TRIALS
trial_result
· 2011-10-25
Clinical Trial Update: Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Summary
Novartis completed a Phase 2 dose-ranging trial in adults with chronic obstructive pulmonary disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: COPD | Phase 2 | Status: COMPLETED